Butterfly Network and Mendaera Collaborate to Commercialize Interventional Robotic System Powered by Butterfly’s Ultrasound-on-Chip™ Technology

Butterfly Network and Mendaera have announced an agreement to commercialize a novel robotic system that is Powered by Butterfly’s Ultrasound-on-Chip™ technology, including a revenue share for each unit sold.

Mendaera’s robotic technology is compatible with Butterfly’s proprietary semiconductor-based ultrasound device and connected via Butterfly’s software development kit – Butterfly Garden™ – creating a system designed to improve the precision and consistency for a broad range of image-guided, needle-based interventions. This new category of robotics will increase access to high quality interventional treatment, ultimately aiming to streamline patient care within a healthcare system burdened by workforce shortages and burnout. Both companies anticipate FDA submission of the product by 2025.

Mendaera’s robotic system is perfectly suited to leverage Butterfly’s proprietary Ultrasound-on-Chip™ by benefiting from the wide array of ultrasonic sensing applications that only our chip can offer,” said Darius Shahida, Chief Strategy Officer of Butterfly Network.

It was a clear choice for us to collaborate with Butterfly on our technology roadmap, given their unique and programmable Ultrasound-on-Chip™ platform and aligned mission to make ultrasound imaging and intervention ubiquitous,” said Josh DeFonzo, Co-Founder and CEO of Mendaera.

To view the source version, please click HERE.